| Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes WK Redekop, MA Koopmanschap, RP Stolk, GEHM Rutten, ... Diabetes care 25 (3), 458-463, 2002 | 850 | 2002 |
| Low-molecular-weight heparin in the treatment of patients with venous thromboembolism Columbus Investigators New England Journal of Medicine 337 (10), 657-662, 1997 | 766 | 1997 |
| The accuracy of hysterosalpingography in the diagnosis of tubal pathology: a meta-analysis P Swart, BWJ Mol, F van der Veen, M van Beurden, WK Redekop, ... Fertility and sterility 64 (3), 486-491, 1995 | 503 | 1995 |
| The CarerQol instrument: a new instrument to measure care-related quality of life of informal caregivers for use in economic evaluations WBF Brouwer, NJA Van Exel, B Van Gorp, WK Redekop Quality of Life Research 15, 1005-1021, 2006 | 396 | 2006 |
| Contrast-enhanced ultrasound using SonoVue®(sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance … M Westwood, M Joore, J Grutters, K Redekop, N Armstrong, K Lee, V Gloy, ... Health technology assessment (Winchester, England) 17 (16), 1, 2013 | 320 | 2013 |
| Comparing methodologies for the cost estimation of hospital services SS Tan, FFH Rutten, BM Van Ineveld, WK Redekop, ... The European Journal of Health Economics 10, 39-45, 2009 | 300 | 2009 |
| Trigeminal neuralgia in multiple sclerosis JP Hooge, WK Redekop Neurology 45 (7), 1294-1296, 1995 | 278 | 1995 |
| Cost-effectiveness of prevention and treatment of the diabetic foot: a Markov analysis MM Ortegon, WK Redekop, LW Niessen Diabetes care 27 (4), 901-907, 2004 | 273 | 2004 |
| A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon TI Verhoef, G Ragia, A de Boer, R Barallon, G Kolovou, V Kolovou, ... New England Journal of Medicine 369 (24), 2304-2312, 2013 | 262 | 2013 |
| Biofeedback training in treatment of childhood constipation: a randomised controlled study RN Van der Plas, MA Benninga, HA Büller, PM Bossuyt, LMA Akkermans, ... The Lancet 348 (9030), 776-780, 1996 | 260 | 1996 |
| The faces of personalized medicine: a framework for understanding its meaning and scope WK Redekop, D Mladsi Value in Health 16 (6), S4-S9, 2013 | 256 | 2013 |
| Predicting mortality in intensive care patients with acute renal failure treated with dialysis. CE Douma, WK Redekop, JH Van Der Meulen, RW Van Olden, J Haeck, ... Journal of the American Society of Nephrology 8 (1), 111-117, 1997 | 210 | 1997 |
| Pharmacogenetic‐guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon TI Verhoef, WK Redekop, AK Daly, RMF Van Schie, A De Boer, ... British journal of clinical pharmacology 77 (4), 626-641, 2014 | 203 | 2014 |
| How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: data extraction, risk of bias, and transferability (part 3/3) BFM Wijnen, G Van Mastrigt, WK Redekop, HJM Majoie, ... Expert review of pharmacoeconomics & outcomes research 16 (6), 723-732, 2016 | 169 | 2016 |
| Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design RMF Van Schie, MIA Wadelius, F Kamali, AK Daly, VG Manolopoulos, ... Pharmacogenomics 10 (10), 1687-1695, 2009 | 167 | 2009 |
| Randomised trial of biofeedback training for encopresis. RN Van der Plas, MA Benninga, WK Redekop, JA Taminiau, HA Büller Archives of Disease in Childhood 75 (5), 367-374, 1996 | 149 | 1996 |
| Blood pressure patterns in rural, semi-urban and urban children in the Ashanti region of Ghana, West Africa C Agyemang, WK Redekop, E Owusu-Dabo, MA Bruijnzeels BMC public health 5, 1-7, 2005 | 134 | 2005 |
| The effects of unfractionated heparin on survival in patients with malignancy–a systematic review SM Smorenburg, RJK Hettiarachchi, R Vink, HR Büller Thrombosis and haemostasis 82 (12), 1600-1604, 1999 | 127 | 1999 |
| Step-by-step guideline for disease-specific costing studies in low-and middle-income countries: a mixed methodology ME Hendriks, P Kundu, AC Boers, OA Bolarinwa, MJ Te Pas, TM Akande, ... Global health action 7 (1), 23573, 2014 | 124 | 2014 |
| Challenges in research and health technology assessment of rare disease technologies: report of the ISPOR rare disease special interest group S Nestler-Parr, D Korchagina, M Toumi, CL Pashos, C Blanchette, ... Value in Health 21 (5), 493-500, 2018 | 120 | 2018 |
